Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2017 1
2018 2
2019 2
2020 5
2021 15
2022 16
2023 12
2024 15

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

62 results

Results by year

Filters applied: . Clear all
Page 1
Antibody-drug conjugates (ADCs) targeting TROP-2 in lung cancer.
Belluomini L, Avancini A, Sposito M, Milella M, Rossi A, Pilotto S. Belluomini L, et al. Expert Opin Biol Ther. 2023 Jul-Dec;23(11):1077-1087. doi: 10.1080/14712598.2023.2198087. Epub 2023 Apr 3. Expert Opin Biol Ther. 2023. PMID: 36995069 Review.
Drive the oncologists into exercise promotion in lung cancer.
Avancini A, Belluomini L, Milella M, Schena F, Novello S, Pilotto S. Avancini A, et al. Among authors: belluomini l. Lung Cancer. 2023 Feb;176:1-3. doi: 10.1016/j.lungcan.2022.12.009. Epub 2022 Dec 22. Lung Cancer. 2023. PMID: 36566581 No abstract available.
Adjuvant Targeted Therapy in Solid Cancers: Pioneers and New Glories.
Sposito M, Belluomini L, Pontolillo L, Tregnago D, Trestini I, Insolda J, Avancini A, Milella M, Bria E, Carbognin L, Pilotto S. Sposito M, et al. Among authors: belluomini l. J Pers Med. 2023 Sep 22;13(10):1427. doi: 10.3390/jpm13101427. J Pers Med. 2023. PMID: 37888038 Free PMC article. Review.
Lung Cancer Screening: An Opportunity to Promote Physical Activity?
Avancini A, Belluomini L, Quist M, Pilotto S. Avancini A, et al. Among authors: belluomini l. JTO Clin Res Rep. 2024 Feb 20;5(3):100651. doi: 10.1016/j.jtocrr.2024.100651. eCollection 2024 Mar. JTO Clin Res Rep. 2024. PMID: 38496375 Free PMC article. No abstract available.
Characterizing the immune tumor microenvironment in ALK fusion-positive lung cancer: state-of-the-art and therapeutical implications.
Sposito M, Eccher S, Pasqualin L, Scaglione IM, Avancini A, Tregnago D, Trestini I, Insolda J, Bonato A, Ugel S, Derosa L, Milella M, Pilotto S, Belluomini L. Sposito M, et al. Among authors: belluomini l. Expert Rev Clin Immunol. 2024 Aug;20(8):959-970. doi: 10.1080/1744666X.2024.2372327. Epub 2024 Jun 26. Expert Rev Clin Immunol. 2024. PMID: 38913940 Review.
Immune checkpoint blockade therapy mitigates systemic inflammation and affects cellular FLIP-expressing monocytic myeloid-derived suppressor cells in non-progressor non-small cell lung cancer patients.
Adamo A, Frusteri C, Pilotto S, Caligola S, Belluomini L, Poffe O, Giacobazzi L, Dusi S, Musiu C, Hu Y, Wang T, Rizzini D, Vella A, Canè S, Sartori G, Insolda J, Sposito M, Incani UC, Carbone C, Piro G, Pettinella F, Qi F, Wang D, Sartoris S, De Sanctis F, Scapini P, Dusi S, Cassatella MA, Bria E, Milella M, Bronte V, Ugel S. Adamo A, et al. Among authors: belluomini l. Oncoimmunology. 2023 Sep 14;12(1):2253644. doi: 10.1080/2162402X.2023.2253644. eCollection 2023. Oncoimmunology. 2023. PMID: 37720688 Free PMC article.
Exercise and Bone Health in Cancer: Enemy or Ally?
Avancini A, Benato G, Borsati A, Oliviero L, Belluomini L, Sposito M, Tregnago D, Trestini I, Insolda J, Zacchi F, Fiorio E, Schena F, Milella M, Pilotto S. Avancini A, et al. Among authors: belluomini l. Cancers (Basel). 2022 Dec 10;14(24):6078. doi: 10.3390/cancers14246078. Cancers (Basel). 2022. PMID: 36551564 Free PMC article. Review.
62 results